Paper1666499
Mechanism of action of sparfloxacin against and mechanism of resistance in gram-negative and gram-positive bacteria.
Piddock LJ and 1 other. Antimicrob Agents Chemother, 1991. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. Mechanism of action of sparfloxacin against and mechanism of resistance in gram-negative and gram-positive bacteria. Papers, record 1666499. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1666499
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mechanism of action of sparfloxacin against and mechanism of resistance in gram-negative and gram-positive bacteria.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fluoroquinolones | Major topic |
| Gram-Negative Bacteria | Major topic |
| Gram-Positive Bacteria | Major topic |
| Quinolones | Major topic |
| Anti-Bacterial Agents | |
| Ciprofloxacin | |
| DNA Probes | |
| DNA, Bacterial | |
| Drug Resistance, Microbial | |
| Enterobacteriaceae | |
| Mutation | |
| Phenotype | |
| Pseudomonas aeruginosa |
Source PubMed
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3532944 | Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3532944 | PubMed |
| 2 | 2658782 | Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2658782 | PubMed |
| 3 | 2110938 | The accumulation of five quinolone antibacterial agents by Escherichia coli. | J Antimicrob Chemother | 1990 | https://conductscience.org/library/papers/2110938 | PubMed |
| 4 | 4570289 | Genetic control of DNA initiation in Escherichia coli. | J Mol Biol | 1973 | https://conductscience.org/library/papers/4570289 | PubMed |
| 5 | 1708224 | Correlation of quinolone MIC and inhibition of DNA, RNA, and protein synthesis and induction of the SOS response in Escherichia coli. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/1708224 | PubMed |
| 6 | 2039209 | In vitro activity of sparfloxacin. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/2039209 | PubMed |
| 7 | 2039202 | Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/2039202 | PubMed |
| 8 | 2024969 | Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/2024969 | PubMed |
| 9 | 1963290 | Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/1963290 | PubMed |
| 10 | 1963286 | Broad-host-range gyrase A gene probe. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/1963286 | PubMed |
| 11 | 2127348 | In vitro activity of sparfloxacin (CI-978; AT-4140) against clinical isolates from cancer patients. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2127348 | PubMed |
| 12 | 2081717 | A comparison of the mechanisms of decreased susceptibility of aztreonam-resistant and ceftazidime-resistant Enterobacteriaceae. | J Antimicrob Chemother | 1990 | https://conductscience.org/library/papers/2081717 | PubMed |
| 13 | 2079449 | In-vitro activity of sparfloxacin, a new quinolone antimicrobial agent. | J Antimicrob Chemother | 1990 | https://conductscience.org/library/papers/2079449 | PubMed |
| 14 | 2285304 | Antistaphylococcal activities of sparfloxacin (CI-978; AT-4140), ofloxacin, and ciprofloxacin. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2285304 | PubMed |
| 15 | 3015000 | Effects of norfloxacin on DNA metabolism in Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3015000 | PubMed |
| 16 | 3010850 | Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3010850 | PubMed |
| 17 | 3056251 | Association between early inhibition of DNA synthesis and the MICs and MBCs of carboxyquinolone antimicrobial agents for wild-type and mutant [gyrA nfxB(ompF) acrA] Escherichia coli K-12. | Antimicrob Agents Chemother | 1988 | https://conductscience.org/library/papers/3056251 | PubMed |
| 18 | 2540707 | Fluorometric assay for fleroxacin uptake by bacterial cells. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2540707 | PubMed |
| 19 | 2679373 | Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2679373 | PubMed |
| 20 | 2168142 | Mechanism of action of lomefloxacin. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2168142 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41034490 | Photosensitizer-specific bacterial stress responses in Escherichia coli reveal distinct targets in photoinduced inactivation. | Commun Biol | 2025 | https://conductscience.org/library/papers/41034490 | PubMed |
| 36144292 | A Robust One-Step Recombineering System for Enterohemorrhagic Escherichia coli. | Microorganisms | 2022 | https://conductscience.org/library/papers/36144292 | PubMed |
| 34248906 | A Novel Device-Integrated Drug Delivery System for Local Inhibition of Urinary Tract Infection. | Front Microbiol | 2021 | https://conductscience.org/library/papers/34248906 | PubMed |
| 25523502 | Unique features of apicoplast DNA gyrases from Toxoplasma gondii and Plasmodium falciparum. | BMC Bioinformatics | 2014 | https://conductscience.org/library/papers/25523502 | PubMed |
| 12069989 | Novel ciprofloxacin-resistant, nalidixic acid-susceptible mutant of Staphylococcus aureus. | Antimicrob Agents Chemother | 2002 | https://conductscience.org/library/papers/12069989 | PubMed |
| 11850266 | Accumulation of 10 fluoroquinolones by wild-type or efflux mutant Streptococcus pneumoniae. | Antimicrob Agents Chemother | 2002 | https://conductscience.org/library/papers/11850266 | PubMed |
| 10681364 | A convenient assay for estimating the possible involvement of efflux of fluoroquinolones by Streptococcus pneumoniae and Staphylococcus aureus: evidence for diminished moxifloxacin, sparfloxacin, and trovafloxacin efflux. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/10681364 | PubMed |
| 9098667 | Sparfloxacin. A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infections. | Drugs | 1997 | https://conductscience.org/library/papers/9098667 | PubMed |
| 8843279 | Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8843279 | PubMed |
| 8494360 | Ciprofloxacin resistance in clinical isolates of Salmonella typhimurium obtained from two patients. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/8494360 | PubMed |
| 8203834 | Activity of Bay y3118 against quinolone-susceptible and -resistant gram-negative and gram-positive bacteria. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/8203834 | PubMed |
| 8192436 | New quinolones and gram-positive bacteria. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/8192436 | PubMed |
| 7689446 | Mechanisms of resistance to quinolones. | Drugs | 1993 | https://conductscience.org/library/papers/7689446 | PubMed |
| 1416840 | Quinolone accumulation in Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus. | Antimicrob Agents Chemother | 1992 | https://conductscience.org/library/papers/1416840 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1666499
GET https://conductscience.org/api/papers/v1/1666499/authors